Alterity Therapeutics (ATHE) Cash & Equivalents (2017 - 2018)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Alterity Therapeutics (ATHE) has 2 years of Cash & Equivalents data on record, last reported at $11.5 million in Q2 2018.

• For Q2 2018, Cash & Equivalents fell 29.84% year-over-year to $11.5 million; the TTM value through Jun 2018 reached $11.5 million, down 29.84%, while the annual FY2018 figure was $11.5 million, 30.11% down from the prior year.
• Cash & Equivalents reached $11.5 million in Q2 2018 per ATHE's latest filing, down from $16.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $16.4 million in Q2 2017 and bottomed at $11.5 million in Q2 2018.

Peer Comparison